03/14/2024
Allogene Therapeutics and Arbor Biotechnologies will use their allogeneic CAR T and next-generation gene-editing platforms to develop novel off-the-shelf CAR-T therapies for autoimmune diseases.
Allogene Therapeutics
- Home
- United States
- South San Francisco, CA
- Allogene Therapeutics
A clinical-stage biotechnology company pioneering the development of AlloCAR T products.
Address
210 E. Grand Avenue
South San Francisco, CA
94080
Website
Alerts
Be the first to know and let us send you an email when Allogene Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Contact The Business
Send a message to Allogene Therapeutics:
